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The acute effects and the time course of fine particulate pollution (PM2.5) on atrial fibrill-
ation/flutter (AF) predictors, including P-wave duration, PR interval duration, and P-wave
complexity, were investigated in a community-dwelling sample of 106 nonsmokers.
Individual-level 24-h beat-to-beat electrocardiogram (ECG) data were visually examined. After
identifying and removing artifacts and arrhythmic beats, the 30-min averages of the AF pre-
dictors were calculated. A personal PM2.5 monitor was used to measure individual-level,
real-time PM2.5 exposures during the same 24-h period, and corresponding 30-min aver-
age PM2.5 concentration were calculated. Under a linear mixed-effects modeling framework,
distributed lag models were used to estimate regression coefficients (βs) associating PM2.5
with AF predictors. Most of the adverse effects on AF predictors occurred within 1.5–2 h after
PM2.5 exposure. The multivariable adjusted βs per 10-µg/m3 rise in PM 2.5 at lag 1 and lag
2 were significantly associated with P-wave complexity. PM2.5 exposure was also significantly
associated with prolonged PR duration at lag 3 and lag 4. Higher PM2.5 was found to be asso-
ciated with increases in P-wave complexity and PR duration. Maximal effects were observed
within 2 h. These findings suggest that PM2.5 adversely affects AF predictors; thus, PM2.5 may
be indicative of greater susceptibility to AF.
Several studies suggested an association
between ambient air pollution and atrial
fibrillation/flutter (AF) (Rich et al., 2006),
stroke, and cardiovascular disease (CVD)
(Miller et al., 2007; Pope et al., 2004), but
the impact of air pollution on AF risk may
have been underestimated (Whitsel and Avery,
2010). Approximately 4% of U.S. adults aged
60 yr or more have been diagnosed with
AF (Go et al., 2001). Moreover, AF is a
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well-established risk factor of ischemic stroke
(Atrial Fibrillation Investigators, 1994). AF is
also a potent risk factor for heart failure (Roy
et al., 2009), and CVD (Atrial Fibrillation
Investigators, 1994). However, it is well recog-
nized that a large proportion of AF cases are
asymptomatic and intermittent. Thus, it is diffi-
cult to investigate AF, either as a consequence
of other exposures such as air pollution expo-
sure, or as the cause of stroke and CVD in
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a healthy population (Soliman et al., 2009).
Meanwhile, several studies identified electro-
cardiogram (ECG) P-wave based measures as
predictors of AF, including paroxysmal forms
of this arrhythmia (Andrikopoulos et al., 2000;
Budeus et al., 2007; Dilaveris et al., 1998;
Gorenek et al., 2007; Materazzo et al., 2007;
Mehta et al., 2000; Ozdemir et al., 2007;
Passman et al., 2001; Raitt et al., 2004; Stafford
et al., 1997). Thus, these P-wave-based mea-
sures are termed AF predictors. Most impor-
tantly, Soliman and coworkers (2009) reported
significant prospective associations between
the AF predictors and the incidence of ischemic
stroke in a large middle-aged population-based
sample. Therefore, in order to investigate AF
pathway as one of the potential mechanisms
that link PM exposure and stroke, one can
investigate the air pollution effects on the P-
wave based AF predictors. Thus, this study was
undertaken to examine the acute effect and
time course of individual-level exposures to
fine PM, defined as particles with aerodynamic
diameter ≤2.5 µm (PM2.5), on the AF predic-
tors in a community-dwelling sample of healthy
individuals.
MATERIALS AND METHODS
Population
For this report, data collected for the Air
Pollution and Cardiac Risk and its Time Course
(APACR) study were used; this study was
designed to investigate the mechanisms and
the time course of the adverse effects of PM2.5
on cardiac electrophysiology, blood coagula-
tion, and systemic inflammation. Recruitment
methods and examination procedures for the
APACR study were published elsewhere (He
et al., 2010; Liao et al., 2010). Briefly, all
study participants were recruited from commu-
nities in central Pennsylvania, primarily from
the Harrisburg metropolitan area, in which the
air pollution level was similar to, if not higher
than, other major metropolitan areas on the
East Coast of the United States. All participants
gave written informed consent prior to their
participation in the study. The inclusion criteria
for the study included nonsmoking adults ≥45
yr old who had not been diagnosed with
severe cardiac problems (defined as diagnosed
valvular heart disease, congenital heart disease,
acute myocardial infarction or stroke within 6
mo, or congestive heart failure). Approximately
75% of the individuals who were contacted
and who met inclusion criteria were enrolled
in the APACR study. Our targeted sample size
was 100 individuals, and 106 individuals were
enrolled and examined for the APACR study.
Study participants were examined at the
Pennsylvania State University General Clinical
Research Center (GCRC) in the morning
between 8 and 10 a.m. on day 1. All partici-
pants fasted for at least 8 h prior to the clinical
examination. After completing a health history
questionnaire, a trained research nurse mea-
sured seated blood pressure thrice, height, and
weight, and drew 50 ml of blood for biomarker
assays according to the blood sample prepa-
ration protocols. A trained investigator con-
nected the PM2.5 and Holter ECG recorders.
Participants were given an hourly activity log
to record special events that occurred over the
next 24 h, including outdoor activities, expo-
sure to traffic on the street, traveling in an auto-
mobile, and any physical activities. The entire
clinical examination session lasted approxi-
mately 1 h. Participants were then released to
proceed with their usual daily routines. The
next morning, the participants returned to the
GCRC to remove the PM2.5 and Holter mon-
itors, deliver the completed activity log, have
another 50 ml of blood drawn, and provide
a urine sample. Then an exercise echocar-
diography was performed on each participant
according to a standardized protocol to mea-
sure the participant’s ventricular function and
structure. The entire day-2 session lasted for
about 1 h and 45 min. Penn State University
College of Medicine Institutional Review Board
approved the study protocol. Each participant
received $50, a certificate for breakfast in the
hospital cafeteria, and compensation for the
mileage associated with travel to and from the
GCRC.
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Personal PM2.5 Exposures
The APACR study used a personal PM2.5
DataRam (pDR, model 1200, Thermo
Scientific, Boston) for real-time 24-h per-
sonal PM2.5 exposure assessment. Details of
the exposure assessment (He et al., 2010; Liao
et al., 2010) and the instrument’s performance
were reported elsewhere (Howard-Reed
et al., 2000; Rea et al., 2001; Wallace et al.,
2006; Williams et al., 2009). Real-time PM2.5
concentrations were initially recorded at
1-min intervals. For each participant, 30-min,
segment-specific averages were calculated on
the whole and half hour, as the PM2.5 expo-
sure variables. The PM2.5 exposure variables
therefore consisted of 48 repeated measures
on each participant.
Continuous Ambulatory ECG and AF
Predictors
A high-fidelity (sampling frequency 1,000
Hz) 12-lead HScribe Holter System (Mortara
Instrument, Inc., Milwaukee, WI) was used to
collect the 24-h Holter beat-to-beat ECG data.
The high-fidelity ECG significantly increases the
resolution and enhances the accuracy of var-
ious waveform measurements. The details of
the Holter ECG data collection and reading
were published by He et al. (2010) and Liao
et al. (2010). In brief, the Holter ECG data were
scanned to a designated computer for offline
processing by an experienced investigator using
a modified version of the Holter System soft-
ware and the SuperECG software (also devel-
oped by Mortara Instrument, Inc.). The main
objectives of the offline processing were to
(1) verify the Holter-identified ECG waves, (2)
identify and label additional electronic artifacts
and arrhythmic beats in the ECG recording,
and (3) perform beat-to-beat ECG analysis used
to estimate various ECG waveform parameters.
Relevant to this study, the following three P-
wave-related measures were calculated as AF
predictors:
P-wave duration (ms), as the time between the
first “onset” and last “offset” deflection from
the isoelectric line.
PR duration (ms), as the time between the
first onset defection of the P and R wave
(the latter representing the onset of ventric-
ular depolarization), with longer PR duration
indicating higher risk of AF.
P-wave complexity (unitless), as the average
ratio of the second to the first eigenvalue,
the value of which reflects the relative
complexity of atrial depolarization (Priori
et al., 1997), with more complexity in the
atrial depolarization indicating the higher
risk of AF.
Heart-Rate Variability (HRV) Variables
Time- and frequency-domain heart-rate
variability (HRV) analyses were performed on
the ECG recording, after removing artifacts
with standardized visual inspection and sta-
tistical filters. HRV indices were calculated
from 30-min segment-specific recordings, after
removing artifacts and ectopic beats, using
HRV Analysis System (Department of Applied
Physics, University of Kuopio, Finland) accord-
ing to current recommendations (Task Force
of the European Society of Cardiology and
the North American Society of Pacing and
Electrophysiology, 1996), and focused on the
following HRV indices as measures of cardiac
autonomic modulation (CAM): standard devi-
ation of all normal RR intervals (SDNN, ms),
square root of the mean of the sum of the
squared differences between adjacent normal
RR intervals (RMSSD, ms), power in the low fre-
quency range (0.04–0.15 Hz, LF), power in the
high frequency range (0.15–0.4 Hz, HF), and
the ratio of LF to HF (LF/HF).
Weather Variables
Real-time temperature and relative humid-
ity were obtained using the HOBO H8 logger
(Onset Computer Corporation, Bourne, MA).
The real-time temperature and relative humid-
ity were recorded at 1-min intervals initially.
For each participant, 30-min segment-specific
averages were calculated, corresponding to
the PM2.5 and Holter measures. Each weather
covariable also consisted of 48 repeated mea-
sures on every participant.
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Other Participant-Level Covariables
A standardized questionnaire administered
on day 1 of the study was used to collect
the following individual-level information: (a)
demographic variables, including age, race,
gender, and highest education level; (b) use
of medication, including anti-anginal, antihy-
pertensive, and antidiabetic agents; and (c)
physician-diagnosed chronic disease history of
CVD (including revascularization procedures
and myocardial infarction), hypertension, and
diabetes. The averages of the second and third
measures of seated systolic and diastolic blood
pressures on day 1 were used to represent a
participant’s blood pressure levels. Day 1 fast-
ing glucose was measured by the Penn State
GCRC central laboratory. CVD was defined
by anti-anginal medication use or a history of
CVD. Hypertension was defined by antihyper-
tensive medication use, physician-diagnosed
hypertension, systolic blood pressure ≥140
mm Hg, or diastolic blood pressure ≥90 mm
Hg. Diabetes was defined by antidiabetic med-
ication use, physician-diagnosed diabetes, or
fasting glucose ≥126 mg/dl. Body mass index
(BMI) was defined as the ratio of weight to
height squared (BMI, kg/m2).
Statistical Analysis
Distributed lag models (Almon, 1965; Pope
& Schwartz, 1996; Schwartz, 2000) were used
under a linear mixed-effects models framework
(Laird & Ware, 1982) with a first-order autore-
gressive covariance structure to (1) model
the correlation between observations from the
same participant and (2) estimate the regres-
sion coefficient between 30-min PM2.5 and
the AF predictors (the outcome variables). All
independent variables were treated as fixed
effects, and time, broken into 30-min seg-
ments, was included as a categorical variable.
This general specification places no specific
functional form of time. Residual diagnostics
were used to assess the appropriateness of
modeling assumption, and no sizeable depar-
tures were detected. In these models, one
lag indicates a 30-min separation between the
exposure and outcome. Thus, lag 0 indicates
the spontaneous relationships between PM2.5
and the AF predictors, and lag 1 indicates 30
min between the PM2.5 and AF predictors, and
so on. A constrained distributed lag model, the
polynomial distributed lag model, was selected
to reduce the potential collinearity of PM2.5
between individual lags using a second-degree
polynomial. The linear mixed-effects model
framework was selected because it allows us
to explicitly model the expected correlation
between measurements taken from the same
participant. As the measurements are equally
spaced, the natural choice for correlation struc-
ture, autoregressive order 1, was used through-
out the analyses to account for the potential
autocorrelation. A second-degree polynomial
for the distributed lag model was used because
the amount of variability in the outcomes of
interest explained by the air pollution mea-
sures is not large, so that the degree of poly-
nomial needs to be selected parsimoniously.
In our experience, second-degree polynomi-
als perform adequately, which is supported by
Schwarz (2000). Another advantage of the dis-
tributed lag model is its ability to facilitate inter-
pretation of the cumulative effects of the lags
included in the model, as well as individual lag
effects. Because the PM2.5 and ECG variables
were assessed in parallel over 48 lags (24 h),
the cut off was decided a priori to model no
more than 10 lags was decided, which allowed
us to fit the distributed lag model using at least
75% of the data. Using P-wave complexity as
the primary outcome variable, models were ini-
tially fitted containing the largest number of
lags (lag 0–10) determined a priori, and reduc-
tion in the total number of individual lags was
made by back-eliminating the longest (e.g., lag
10) in succession until a significant cumulative
effect (p < .05) was identified (lag 0 to lag 3 for
P-wave complexity in this report). This model
was then used as our final model for the other
two AF predictors (PR interval and P durations).
Because the cumulative effects including lag 0
to lag 3 in the model were not significant for
these two AF predictors, one more lag (lag 4)
was forced into the model to avoid potential
underascertainment of significant cumulative
effect on these two AF predictors. All results
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are expressed per 10-µg/m3 increase in PM2.5.
In the final models, all time-dependent covari-
ables, such as weather and HRV variables, were
entered in the models using the same dis-
tributed lag structure as the PM2.5 variable.
SAS version 9 (SAS Institute, Inc., Cary, NC)
was used for all analyses. The criterion for
significance was set at p < .05.
RESULTS
The demographic and CVD risk profiles of
the study population are presented in Table 1.
The mean age of the participants was 56 yr,
with 74% non-Hispanic white, 26% minorities
(including Blacks, Hispanics, and Chinese),
59% female, and 43% having chronic diseases
(mostly hypertension). At the population level,
the distributions of both the PM2.5 exposure
and AF predictors were approximately normal.
The temporal distributions of the PM2.5 and PR
duration are presented in Figures 1 and 2, each
of which plots means and standard deviations
versus time of day. Both the PM2.5 and AF
predictor exhibited substantial variation within
24 h, and within 30-min averaging periods
between participants. Excluding 48 (0.94%) of
the 30-min segments in which the proportion
of artifacts and arrhythmic beats exceeded 20%
of recording time left 5040 pairs of 30-min
PM2.5 exposure and AF predictor data points
collected from 106 individuals over a 24-h
period.
The cumulative effects and individual lag
effects of PM2.5 on each of the AF predic-
tors are summarized in Table 2 as multivari-
able adjusted regression coefficients β (SE, p
value) associated with PM2.5 exposure (per
10-µg/m3 increment in PM2.5). In summary,
elevated PM2.5 was positively associated with
P-wave complexity and PR duration. A sig-
nificant cumulative effect was observed for
P-wave complexity and a quantitative cumu-
lative effect on PR duration. PM2.5 was not
significantly associated with P-wave duration.
Examining the individual lag effects, the mul-
tivariable adjusted regression coefficients for a
10-µg/m3 rise in PM2.5 were significant for lag
1 and lag 2 (approximately 0.5–1 h after the
elevation of PM2.5) for P-wave complexity, and
lag 3 and lag 4 (approximately 1.5–2 h after
PM2.5 increase) for PR duration, respectively. In
summary, both individual lag effects and cumu-
lative effects from the data presented in Table 2
suggest an acute response of these AF predic-
tors to PM2.5 exposures. Additional adjustment
TABLE 1. Demographic Characteristics and Health Status of the Study Population
Hypertension, diabetes, or CVD
All subjects, No, Yes,
Characteristic n= 106 n= 60 n= 46
Age (yr) 56.23 (7.61) 55.55 (8.19) 57.12 (6.76)
Gender (% male) 40.57 40.00 41.30
Race (% white) 73.58 71.67 76.09
Glucose (mg/dl) 88.82 (25.14) 84.64 (10.04) 94.29 (35.95)
BMI (kg/m2) 27.71 (5.86) 26.19 (4.31) 29.69 (6.98)
CVD (%) 8.49 0.00 19.57
Hypertension (%) 34.91 0.00 84.78
Diabetes (%) 7.55 0.00 17.39
Systolic BP (mm Hg) 121.88 (15.73) 117.05 (11.86) 128.18 (17.93)
Diastolic BP (mm Hg) 75.07 (9.22) 73.12 (8.34) 77.62 (9.77)
College or higher (%) 78.30 73.33 84.78
PR duration (ms) 159.06 (20.27) 157.93 (20.89) 160.53 (19.34)
P duration (ms) 108.14 (11.31) 107.72 (11.47) 108.70 (11.07)
P complexity 0.21 (0.08) 0.20 (0.09) 0.21 (0.07)
PM2.5 (µg/m3) 13.61 (21.59) 11.86 (14.69) 15.87 (27.95)
Temperature (◦C) 21.76 (3.53) 21.84 (3.66) 21.66 (3.36)
Relative humidity (%) 39.66 (12.08) 40.18 (12.30) 38.98 (11.76)
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FIGURE 1. Time-specific mean PM2.5 exposure over 24 h in the APACR study.
FIGURE 2. Time-specific mean PR duration over 24 h in the APACR Study.
for chronic disease (model 2 in Table 2) did
not change the pattern of association from
the models adjusted only for major demo-
graphic and weather-related variables (model 1
in Table 2).
To elucidate the role of CAM on the rela-
tionship between PM2.5 exposure and AF pre-
dictors, model 2 in Table 2 was repeated for
P-wave complexity and PR duration outcomes
after adjusting for HRV and heart rate (HR)
measures, using one HRV or HR variable at
a time. The HRV and HR adjusted regres-
sion coefficients are presented in Table 3. In
summary, the overall patterns of associations
between PM2.5 and these two AF predictors
were greatly attenuated, but mostly remained
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TABLE 2. Regression Coefficient of AF Predictors Associated With a 10-µg/m3 Increment of PM2.5 Concentration
Regression coefficient (SE, p value)
P-wave variable Lags Model 1 Model 2
P complexity Lag 0 0.0002 (0.0002, p = .47) 0.0002 (0.0002, p = .49)
Lag 1 0.0004 (0.0002, p = .01) 0.0004 (0.0002, p = .01)
Lag 2 0.0005 (0.0002, p < 0.01) 0.0005 (0.0002, p < .01)
Lag 3 0.0004 (0.0004, p = .31) 0.0004 (0.0004, p = .32)
Cumulative 0.0016 (0.0006, p = .01) 0.0016 (0.0006, p = .01)
PR duration Lag 0 −0.022 (0.036, p = .54) −0.023 (0.036, p = .53)
Lag 1 −0.009 (0.025, p = .70) −0.010 (0.025, p = .68)
Lag 2 0.023 (0.031, p = .46) 0.022 (0.031, p = .48)
Lag 3 0.075 (0.037, p = .05) 0.074 (0.037, p = .05)
Lag 4 0.146 (0.068, p = .03) 0.145 (0.068, p = .03)
Cumulative 0.213 (0.133, p = .11) 0.207 (0.133, p = .12)
P duration Lag 0 0.014 (0.030, p = .65) 0.013 (0.030, p = .67)
Lag 1 −0.016 (0.020, p = .43) −0.017 (0.020, p = .41)
Lag 2 −0.023 (0.026, p = .36) −0.024 (0.026, p = .35)
Lag 3 −0.008 (0.032, p = .79) −0.009 (0.032, p = .77)
Lag 4 0.029 (0.058, p = .62) −0.028 (0.058, p = .63)
Cumulative −0.005 (0.110, p = .96) −0.009 (0.111, p = .94)
Note. Model 1: adjusted for age, gender, race, temperature, and relative humidity. Model 2: adjusted for age, gender,
race, temperature, relative humidity, diabetes, hypertension, and CVD.
statistically significant with additional adjust-
ment for HRV and HR variables as measures
of CAM.
The interaction terms between PM2.5 and
CVD-related chronic conditions were tested;
none were statistically significant (data not
shown). Therefore, the effects of PM2.5 on P-
wave-related variables did not differ depending
on whether an individual had previous CVD-
related conditions. Stratified analysis according
to chronic disease status revealed similar asso-
ciations among participants with and without
CVD-related conditions (data not shown).
DISCUSSION
Although epidemiologic studies consis-
tently showed an association between expo-
sure to increased PM air pollution and risk of
CVD (Dominici et al., 2005; Franklin et al.,
2007, 2008; Krewski et al., 2005; Ostro et al.,
2006; Yang et al., 2004; Zanobetti & Schwartz,
2009) and stroke (Miller et al., 2007; Pope
et al., 2004), the mechanisms responsible
for such an association have not been fully
identified. Since AF is a well-established risk
factor for stroke, it is biologically plausible
that PM and stroke relationship may be medi-
ated in part by PM-related increases in AF
risk. This potential mechanism is supported by
data from Rich and coworkers (2006), who
reported an elevated risk of paroxysmal AF
after an acute gaseous air pollution exposure
in patients wearing implantable cardioverter-
defibrillators (ICDs). The association, however,
may not be generalizable to a healthy popu-
lation. Indeed, there has been no publication
of such a relationship in healthy community-
based samples. Given the asymptomatic and
intermittent nature of AF in healthy individu-
als and the established relationship between AF
predictors and future AF and the risk of incident
stroke, this study was conducted to exam-
ine the temporal relationship and between
PM2.5 exposures and AF predictors in a healthy
community-dwelling sample of nonsmokers,
and through such association to elucidate
the PM2.5 effects on susceptibility to AF and
stroke. The operational hypothesis is that acute
exposures to PM2.5 are associated with predic-
tors of AF. If the association is confirmed, this
would suggest that exposure to PM2.5 is also
associated with higher risk of AF development
and thereby stroke.
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In this study, acute exposure to PM2.5
significantly affected P-wave complexity and
PR duration, but not P-wave duration. Overall,
these findings support our a priori hypothesis.
Specifically, data suggested that elevated PM2.5
was associated with more complex P-wave
morphology and longer PR duration, and both
are indicative of disturbed atrial depolariza-
tion. Similar to our previous findings, in the
same population, of PM2.5 effects on HRV
(He et al., 2010) or QT intervals (Liao et al.,
2010), the effect size of PM2.5 on AF pre-
dictors is relatively small. From the etiologic
perspective, the small effect indicates a weak
influence of PM2.5 on risk of AF. Therefore,
the changes of AF predictors due to PM expo-
sure in this population-based healthy sample
may not be clinically relevant. However, con-
sidering the fact that the entire U.S. population
is exposed to ambient, indoor, and personal
sources of PM2.5, on a continuous, daily basis,
minor PM2.5 elevation may possess a greater
impact on the cardiovascular health of the pub-
lic than is generally appreciated. Moreover, the
effects on AF predictors in this study were
measured in generally healthy individuals. It
is possible that PM2.5 effects on AF predic-
tors may be greater among those with under-
lying structural heart disease, ischemic heart
disease, or heart failure, although the lower
power tests of such interactions in this context
did not support this possibility. Future stud-
ies could target clinical subgroups likely to
be more PM-susceptible, especially those ren-
dered more vulnerable by residential proximity
to important PM2.5 sources, e.g., highways.
Although several animal-based studies
showed that PM (Gordon et al., 2000), diesel
exhaust (Campen et al., 2003), cigarette smok-
ing (Rai et al., 1983), and highly toxic fly ash
PM (Hazari et al., 2009) exposure were asso-
ciated with PR prolongation, the mechanisms
responsible for PM induced changes in P-
wave based ECG measures are not fully under-
stood. The results presented in Table 3 indi-
cate that the magnitude of association between
PM2.5 and P-complexity and PR duration were
greatly attenuated but mostly remained sta-
tistically significant after adjusting for cardiac
autonomic modulation as potential interme-
diating factors. To our knowledge, this is the
first study to demonstrate the above summa-
rized findings in a healthy community-dwelling
sample. If such an attenuation effect can be
confirmed by other human- and animal-based
studies, this would suggest that PM exposure
first produces an acute imbalance of auto-
nomic modulation, characteristic of increased
sympathetic and decreased parasympathetic
modulations. Through the autonomic modula-
tion mechanism, PMmight lead to disturbances
of P-wave-based ECG parameters that are
indicative of higher susceptibility to AF. Other
potential mechanisms may include, first, PM
induced coronary artery constriction, which is
supported by the observation by Brook and
coworkers (2002), who reported a sudden con-
duit vasoconstriction after a short-term PM2.5
and O3 exposure in a sample of healthy volun-
teers. Mills and coworkers (2005) also demon-
strated similar patterns. Second, PM may also
decrease the oxygen–carrying capacity of the
blood, as supported by studies reported by sev-
eral investigators (Clarke et al., 2000; Savage
et al., 2002; Seaton et al., 1999). Lastly, it is
also plausible that PM exerts a direct adverse
effect on cardiac electrophysiological param-
eters, such as AF predictors examined in this
study. More mechanistic studies are needed to
investigate the exact pathways from PM expo-
sure to the adverse cardiac electrophysiological
effects. Considering the large attenuation of PM
effects on P-wave complexity and PR dura-
tion, after adjustment of HRV and HR, cardiac
autonomic modulation was considered as the
predominant mechanism.
The strengths of our study include that
both the PM2.5 exposure and the AF predic-
tors were measured from individual levels on
a real-time basis over 24 h. The exposure
and the outcome data were treated as 30-min
repeated measures, and thus benefited from
increased statistical power in associating the
exposure and outcomes. This type of data also
enabled us to control for many individual-level
unmeasured factors that may influence the AF
predictors. Although the results generated from
this study are compelling, there are still several
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limitations. First, smokers and people who had
severe cardiac events in the past 6 mo were
excluded. Therefore, one may not be able to
generalize the association seen in these data to
individuals with more severe CVD. It is possi-
ble that PM2.5 effects on AF predictors might
be greater in individuals with underlying struc-
tural heart disease, ischemic heart disease, or
heart failure. Second, most of the participants
reported that they stayed indoors the major-
ity of the time during the 24-h study period,
except when they had to travel by automo-
bile. This behavior pattern is reflected in the
relatively low levels of exposure to PM2.5. In
general, our participants had limited indoor
exposures, e.g., secondhand smoke. Thus, it
was not possible to assess whether exposures
at much higher levels would exhibit similar
associations. However, the personal monitors
and real-time Holter system were purposely
used to collect the true individual-level expo-
sure and routine ECG data, respectively. The
associations observed in these individuals may
be more reflective of their routine exposure
and outcome associations. Third, it is well
known that HR increases during physical activ-
ity, which could be related to higher PM2.5
exposure if it occurs outdoors. It is also well
known that PR duration is HR dependent. Thus
it is possible that the PM2.5 and AF predic-
tors association in this study is confounded
by physical activity that occurred during some
segment of the 24-h study period. However,
since most of participants reported that they
stay indoors for the vast majority of the time
during 24-h period, it is unlikely that the asso-
ciation is solely due to physical activity outside
of their homes, which is also supported by
the findings of significant associations between
PM2.5 and AF predictors after adjustment of
lag-specific HR in Table 3. Fourth, the Holter
ECG data were not collected in a controlled set-
ting or the conventional supine position. Thus,
the short-term variation of other factors that
may impact the ECG measures can not be fully
accounted for. However, it is not feasible to
keep a healthy participant in a supine indoor
position for 24 h. Even if this were achieved,
the results from such a study design would
likely have limited variation in PM2.5 expo-
sure levels, and would have limited utility for
generalization to a real world situation. In con-
trast, our study captures the range of activities
occurring in real life, including time spent out-
doors, time spent commuting in an automo-
bile, and various other activities undertaken
by typical community-dwelling individuals free
of chronic disease. Fifth, the sample size of
this study is small, and individuals with chronic
conditions consisted mostly of well-controlled
hypertensives. As a result, the statistical power
was limited to detect significant effect modi-
fication by chronic disease status. Lastly, pDR
estimated PM2.5 concentrations over 24 h were
used in this study as an estimation of personal
exposures. This nephelometric device responds
to the optical as opposed to the true gravimet-
ric properties of the particles it encounters. It
should be recognized that the optical proper-
ties (calibrated using Arizona road dust) might
not be highly representative of the actual PM2.5
aerosol the study participants encountered.
Previous studies reported that the Arizona road
dust calibrated pDR, identical to the one used
in this study, provides mass concentration esti-
mates in reliable agreement with that from
gravimetric mass-based measures (correlation
coefficients >0.8), but 10–50% higher than
those from gravimetric mass-based measures
(Howard-Reed et al., 2000; Rea et al., 2001;
Williams et al., 2009). Based on these val-
idation studies, the personal exposures used
in this study might systematically overestimate
the true environmental conditions that existed.
However, this systematic overestimation of the
true exposures to PM2.5 should not have biased
the pattern of the observed associations. Under
the assumption that the pDR systematically
overestimates the true exposure by 10–50%,
it can be argued that the reported effect sizes
per 10-µg/m3 increase in the pDR estimated
PM2.5 reported here actually represents effects
per 6.67–9 µg/m3 increase in the true PM2.5
exposure. By extension, this implies that the
reported effect in this study may be systemat-
ically underestimated.
In summary, acute exposure to PM2.5 at
the individual level is directly associated with
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longer PR duration and more complexity of
atrial depolarization, and the time to such an
effect is approximately 1.5–2 h. The adverse
effect of PM2.5 on these AF predictors is
independent of major confounding factors and
cannot be attributed solely to its autonomic
effects. Overall, these findings support the
possibility that PM2.5 may affect vulnerability
to atrial fibrillation/flutter, and partly through
such a mechanism, higher exposures to PM2.5
increase the risk of AF and ischemic stroke.
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